Who is sponsoring SCLEROKINE?

SCLEROKINE is sponsored by Poitiers University Hospital.

What condition does SCLEROKINE study?

SCLEROKINE studies Systemic Sclerosis.

What is the status of SCLEROKINE?

SCLEROKINE is currently COMPLETED.

Last reviewed 2020-04-21 · How we verify

Analysis of Cytokine Expression Pattern in Systemic Sclerosis (SCLEROKINE)

NCT03537105 NA COMPLETED

By contrast to other proinflammatory cytokines which are found up-regulated in the skin of patients with psoriasis, atopic dermatitis or systemic sclerosis, IL-34 is the only cytokine that undergoes down-regulation. This finding is interesting regarding the description of IL-34 as an immunosuppressive cytokine. In this study, the expression and the role of interleukin-34 (IL-34) will be investigated in the physiopathology of systemic sclerosis.

Details

Lead sponsor	Poitiers University Hospital
Phase	NA
Status	COMPLETED
Enrolment	22
Start date	Thu Jul 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Sep 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Systemic Sclerosis

Interventions

Skin biopsies

Countries

France